89 related articles for article (PubMed ID: 18767093)
1. Regulation of human carbonic anhydrase I (hCAI) activity by using a photochromic inhibitor.
Vomasta D; Högner C; Branda NR; König B
Angew Chem Int Ed Engl; 2008; 47(40):7644-7. PubMed ID: 18767093
[No Abstract] [Full Text] [Related]
2. Catalytic inactivation of human carbonic anhydrase I by a metallopeptide-sulfonamide conjugate is mediated by oxidation of active site residues.
Gokhale NH; Bradford S; Cowan JA
J Am Chem Soc; 2008 Feb; 130(8):2388-9. PubMed ID: 18251475
[No Abstract] [Full Text] [Related]
3. Benzimidazo[1,2-c][1,2,3]thiadiazole-7-sulfonamides as inhibitors of carbonic anhydrase.
Dudutiene V; Baranauskiene L; Matulis D
Bioorg Med Chem Lett; 2007 Jun; 17(12):3335-8. PubMed ID: 17442568
[TBL] [Abstract][Full Text] [Related]
4. Effects of new 5-amino-1,3,4-thiadiazole-2-sulfonamide derivatives on human carbonic anhydrase isozymes.
Kasimoğullari R; Bülbül M; Günhan H; Güleryüz H
Bioorg Med Chem; 2009 May; 17(9):3295-301. PubMed ID: 19362844
[TBL] [Abstract][Full Text] [Related]
5. Two-prong inhibitors for human carbonic anhydrase II.
Roy BC; Banerjee AL; Swanson M; Jia XG; Haldar MK; Mallik S; Srivastava DK
J Am Chem Soc; 2004 Oct; 126(41):13206-7. PubMed ID: 15479058
[TBL] [Abstract][Full Text] [Related]
6. Discovery of begacestat, a Notch-1-sparing gamma-secretase inhibitor for the treatment of Alzheimer's disease.
Mayer SC; Kreft AF; Harrison B; Abou-Gharbia M; Antane M; Aschmies S; Atchison K; Chlenov M; Cole DC; Comery T; Diamantidis G; Ellingboe J; Fan K; Galante R; Gonzales C; Ho DM; Hoke ME; Hu Y; Huryn D; Jain U; Jin M; Kremer K; Kubrak D; Lin M; Lu P; Magolda R; Martone R; Moore W; Oganesian A; Pangalos MN; Porte A; Reinhart P; Resnick L; Riddell DR; Sonnenberg-Reines J; Stock JR; Sun SC; Wagner E; Wang T; Woller K; Xu Z; Zaleska MM; Zeldis J; Zhang M; Zhou H; Jacobsen JS
J Med Chem; 2008 Dec; 51(23):7348-51. PubMed ID: 19012391
[TBL] [Abstract][Full Text] [Related]
7. Carbonic anhydrase inhibitors. Aromatic/heterocyclic sulfonamides incorporating phenacetyl, pyridylacetyl and thienylacetyl tails act as potent inhibitors of human mitochondrial isoforms VA and VB.
Güzel O; Innocenti A; Scozzafava A; Salman A; Supuran CT
Bioorg Med Chem; 2009 Jul; 17(14):4894-9. PubMed ID: 19539481
[TBL] [Abstract][Full Text] [Related]
8. Carbonic anhydrase-encoded dynamic constitutional libraries: toward the discovery of isozyme-specific inhibitors.
Nasr G; Petit E; Vullo D; Winum JY; Supuran CT; Barboiu M
J Med Chem; 2009 Aug; 52(15):4853-9. PubMed ID: 19580287
[TBL] [Abstract][Full Text] [Related]
9. Carbonic anhydrase inhibitors. Inhibition of human erythrocyte isozymes I and II with a series of antioxidant phenols.
Sentürk M; Gülçin I; Daştan A; Küfrevioğlu OI; Supuran CT
Bioorg Med Chem; 2009 Apr; 17(8):3207-11. PubMed ID: 19231207
[TBL] [Abstract][Full Text] [Related]
10. S-glycosyl primary sulfonamides--a new structural class for selective inhibition of cancer-associated carbonic anhydrases.
Lopez M; Paul B; Hofmann A; Morizzi J; Wu QK; Charman SA; Innocenti A; Vullo D; Supuran CT; Poulsen SA
J Med Chem; 2009 Oct; 52(20):6421-32. PubMed ID: 19827837
[TBL] [Abstract][Full Text] [Related]
11. Dorzolamide hydrochloride: an antiglaucoma agent.
Ravikumar K; Sridhar B
Acta Crystallogr C; 2007 Feb; 63(Pt 2):o108-10. PubMed ID: 17284800
[No Abstract] [Full Text] [Related]
12. Discovery of a new class of protein farnesyltransferase inhibitors in the arylthiophene series.
Lethu S; Ginisty M; Bosc D; Dubois J
J Med Chem; 2009 Oct; 52(20):6205-8. PubMed ID: 19772293
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and anticancer evaluation of novel tetrahydroquinoline derivatives containing sulfonamide moiety.
Ghorab MM; Ragab FA; Hamed MM
Eur J Med Chem; 2009 Oct; 44(10):4211-7. PubMed ID: 19540022
[TBL] [Abstract][Full Text] [Related]
14. Tetrahydrobenzothiophene derivatives: conformationally restricted inhibitors of type II dehydroquinase.
Paz S; Tizón L; Otero JM; Llamas-Saiz AL; Fox GC; van Raaij MJ; Lamb H; Hawkins AR; Lapthorn AJ; Castedo L; González-Bello C
ChemMedChem; 2011 Feb; 6(2):266-72. PubMed ID: 21275050
[No Abstract] [Full Text] [Related]
15. Carbonic anhydrase inhibitors: inhibition of the beta-class enzyme from the yeast Saccharomyces cerevisiae with sulfonamides and sulfamates.
Isik S; Kockar F; Aydin M; Arslan O; Guler OO; Innocenti A; Scozzafava A; Supuran CT
Bioorg Med Chem; 2009 Feb; 17(3):1158-63. PubMed ID: 19124253
[TBL] [Abstract][Full Text] [Related]
16. The effect of carbonic anhydrase inhibition on leptin secretion by rat adipose tissue.
Alver A; Keha EE; Uçar F; Ovali E
J Enzyme Inhib Med Chem; 2004 Apr; 19(2):181-4. PubMed ID: 15449734
[TBL] [Abstract][Full Text] [Related]
17. In vitro inhibition of salicylic acid derivatives on human cytosolic carbonic anhydrase isozymes I and II.
Bayram E; Senturk M; Kufrevioglu OI; Supuran CT
Bioorg Med Chem; 2008 Oct; 16(20):9101-5. PubMed ID: 18819808
[TBL] [Abstract][Full Text] [Related]
18. Carbonic anhydrase inhibitors. Phenacetyl-, pyridylacetyl- and thienylacetyl-substituted aromatic sulfonamides act as potent and selective isoform VII inhibitors.
Güzel O; Innocenti A; Scozzafava A; Salman A; Supuran CT
Bioorg Med Chem Lett; 2009 Jun; 19(12):3170-3. PubMed ID: 19435663
[TBL] [Abstract][Full Text] [Related]
19. Small-molecule suppression of misfolding of mutated human carbonic anhydrase II linked to marble brain disease.
Almstedt K; Rafstedt T; Supuran CT; Carlsson U; Hammarström P
Biochemistry; 2009 Jun; 48(23):5358-64. PubMed ID: 19415900
[TBL] [Abstract][Full Text] [Related]
20. Carbonic anhydrase inhibitors: 2-substituted-1,3,4-thiadiazole-5-sulfamides act as powerful and selective inhibitors of the mitochondrial isozymes VA and VB over the cytosolic and membrane-associated carbonic anhydrases I, II and IV.
Smaine FZ; Pacchiano F; Rami M; Barragan-Montero V; Vullo D; Scozzafava A; Winum JY; Supuran CT
Bioorg Med Chem Lett; 2008 Dec; 18(24):6332-5. PubMed ID: 18990571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
